tech talk
Since I joined last year, I haven’ t come across any major concern on funding or the lack of it. The purchases continue to happen in both private and government segments. So, I think the funding crunch has eased a bit. Also, initially the government would fund any project it wanted to but now it is asking questions on the utility.
They are asking how much is the translational research, the number of research papers, and the benefit to society. Some institutes were used to unquestioned funding but now they have to answer the question, which of course is a good move on the part of government. They have the responsibility to produce something that will help in making life simpler, healthier and better. The taxpayers’ money now must have accountability.
Q: What are the set of clients you cater to?
Our customers are researchers and scientists both in institutes and private sector. Apart from that clinicians and pathological labs such as Dr Lal PathLabs,
46 BioVoiceNews | March 2017